{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:29:37Z","timestamp":1791829777533,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Dermatol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The impact of Malassezia yeasts on skin mycobiome and health has received considerable attention recently. <jats:italic>Pityriasis versicolor<\/jats:italic> (PV), a common dermatosis caused by Malassezia genus worldwide, is a manifestation of dysbiosis. PV can be associated with hyper- and\/or hypopigmented skin lesions. This disease entity is characterized by high percentage of relapses, which demands a proper antifungal therapy that is based on unambiguous species identification and drug susceptibility testing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Comprehensive analysis of PV case in man presenting simultaneously hyper- and hypopigmented skin lesions was performed. Conventional and molecular diagnostic procedures revealed <jats:italic>Malassezia furfur<\/jats:italic> and <jats:italic>Malassezia sympodialis,<\/jats:italic> respectively as etiological agents of skin lesions observed. Susceptibility tests showed significantly lowered sensitivity of <jats:italic>M. furfur<\/jats:italic> cells to fluconazole. Based on susceptibility profiles local antifungal therapy with drugs characterized by entirely different mechanism of action was included.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study indicates that cases of PV represented by two types of skin lesions in one patient may be associated with distinct Malassezia species. Moreover, as observed in this case, each of the isolated etiological agents of PV may differ significantly in susceptibility to antifungals. This can significantly complicate the treatment of dermatosis, which by definition is associated with a significant percentage of relapses. In the presented case localized topical treatment was sufficient and successful while allowing maintaining the physiological mycobiome.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12895-020-00106-x","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T13:02:49Z","timestamp":1601384569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A case of anti- pityriasis versicolor therapy that preserves healthy mycobiome"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2062-6169","authenticated-orcid":false,"given":"Mariusz","family":"Dyl\u0105g","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Leniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Gnat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek C.","family":"Szepietowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Kozubowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"key":"106_CR1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1128\/CMR.00021-11","volume":"25","author":"G Gaitanis","year":"2012","unstructured":"Gaitanis G, Magiatis P, Hantschke M, Bassukas ID, Velegraki A. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev. 2012;25:106\u201341.","journal-title":"Clin Microbiol Rev"},{"key":"106_CR2","doi-asserted-by":"publisher","first-page":"e1005614","DOI":"10.1371\/journal.pgen.1005614","volume":"11","author":"G Wu","year":"2015","unstructured":"Wu G, Zhao H, Li C, et al. Genus-wide comparative genomics of Malassezia delineates its phylogeny, physiology, and niche adaptation on human skin. PLoS Genet. 2015;11:e1005614.","journal-title":"PLoS Genet"},{"key":"106_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/jof5040088","volume":"5","author":"TK Tenagy","year":"2019","unstructured":"Tenagy TK, Chen X, Iwatani S, Kajiwara S. Long-chain acyl-CoA synthetase is associated with the growth of Malassezia spp. J Fungi (Basel). 2019;5:88.","journal-title":"J Fungi (Basel)"},{"key":"106_CR4","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0140-6736(04)17107-9","volume":"364","author":"RA Schwartz","year":"2004","unstructured":"Schwartz RA. Superficial fungal infections. Lancet. 2004;364:1173\u201382.","journal-title":"Lancet"},{"key":"106_CR5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/ijd.13116","volume":"55","author":"A Prohic","year":"2016","unstructured":"Prohic A, Jovovic Sadikovic T, Krupalija-Fazlic M, Kuskunovic-Vlahovljak S. Malassezia species in healthy skin and in dermatological conditions. Int J Dermatol. 2016;55:494\u2013504.","journal-title":"Int J Dermatol"},{"key":"106_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrmicro.2017.157","volume":"16","author":"A Byrd","year":"2018","unstructured":"Byrd A, Belkaid Y, Segre J. The human skin microbiome. Nat Rev Microbiol. 2018;16:143\u201355.","journal-title":"Nat Rev Microbiol"},{"key":"106_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nature12171","volume":"498","author":"K Findley","year":"2013","unstructured":"Findley K, Oh J, Yang J, et al. Topographic diversity of fungal and bacterial communities in human skin. Nature. 2013;498:367\u201370.","journal-title":"Nature"},{"key":"106_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3314\/mmj.54.39","volume":"54","author":"T Sugita","year":"2013","unstructured":"Sugita T, Zhang E, Tanaka T, et al. Recent advances in research on Malassezia microbiota in humans. Med Mycol J. 2013;54:39\u201344.","journal-title":"Med Mycol J"},{"key":"106_CR9","doi-asserted-by":"publisher","first-page":"3486","DOI":"10.1128\/JCM.39.10.3486-3490.2001","volume":"39","author":"T Sugita","year":"2001","unstructured":"Sugita T, Suto H, Unno T, et al. Molecular analysis of Malassezia microflora on the skin of atopic dermatitis patients and healthy subjects. J Clin Microbiol. 2001;39:3486\u201390.","journal-title":"J Clin Microbiol"},{"key":"106_CR10","doi-asserted-by":"publisher","first-page":"e1361573","DOI":"10.1080\/19381980.2017.1361573","volume":"9","author":"CSL Kamamoto","year":"2017","unstructured":"Kamamoto CSL, Nishikaku AS, Gompertz OF, Melo AS, Hassun KM, Bagatin E. Cutaneous fungal microbiome: Malassezia yeasts in seborrheic dermatitis scalp in a randomized, comparative and therapeutic trial. Dermatoendocrinol. 2017;9:e1361573.","journal-title":"Dermatoendocrinol"},{"key":"106_CR11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fcimb.2018.00346","volume":"8","author":"R Saxena","year":"2018","unstructured":"Saxena R, Mittal P, Clavaud C, et al. Comparison of healthy and dandruff scalp microbiome reveals the role of commensals in scalp health. Front Cell Infect Mi. 2018;8:346.","journal-title":"Front Cell Infect Mi"},{"key":"106_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/00001432-200204000-00006","volume":"15","author":"V Crespo-Erchiga","year":"2002","unstructured":"Crespo-Erchiga V, Delgado-Florencio V. Malassezia species in skin diseases. Curr Opin Infect Dis. 2002;15:133\u201342.","journal-title":"Curr Opin Infect Dis"},{"key":"106_CR13","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/1346-8138.12700","volume":"42","author":"K Harada","year":"2015","unstructured":"Harada K, Saito M, Sugita T, Tsuboi R. Malassezia species and their associated skin diseases. J Dermatol. 2015;42:250\u20137.","journal-title":"J Dermatol"},{"key":"106_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2340\/00015555-0079","volume":"86","author":"J Faergemann","year":"2006","unstructured":"Faergemann J, Ausma J, Borgers M. In vitro activity of R126638 and ketoconazole against Malassezia species. Acta Derm-Venereol. 2006;86:1\u20134.","journal-title":"Acta Derm-Venereol"},{"key":"106_CR15","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-3-642-03616-3_2","volume-title":"Malassezia and the skin: science and clinical practice","author":"E Gu\u00e9ho","year":"2010","unstructured":"Gu\u00e9ho E, Boekhout T, Begerow D. Biodiversity, phylogeny and ultrastructure. In: Boekhout T, Gu\u00e9ho E, Mayser P, Velegraki A, editors. Malassezia and the skin: science and clinical practice. Berlin Heidelberg: Springer-Verlag; 2010. p. 17\u201363."},{"key":"106_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1023\/A:1016020209891","volume":"154","author":"C Aspiroz","year":"2002","unstructured":"Aspiroz C, Ara M, Varea M, Rezusta A, Rubio C. Isolation of Malassezia globosa and M. sympodialis from patients with pityriasis versicolor in Spain. Mycopathologia. 2002;154:111\u20137.","journal-title":"Mycopathologia."},{"key":"106_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/01.qco.0000216624.21069.61","volume":"19","author":"V Crespo-Erchiga","year":"2006","unstructured":"Crespo-Erchiga V, Delgado-Florencio V. Malassezia yeasts and pityriasis versicolor. Curr Opin Infect Dis. 2006;19:139\u201347.","journal-title":"Curr Opin Infect Dis"},{"key":"106_CR18","first-page":"74","volume-title":"Malassezia and the skin: science and clinical practice","author":"V Crespo-Erchiga","year":"2010","unstructured":"Crespo-Erchiga V, Hay RJ. Pityriasis Versicolor and other Malassezia skin diseases. In: Boekhout T, Gu\u00e9ho E, Mayser P, Velegraki A, editors. Malassezia and the skin: science and clinical practice. Berlin Heidelberg: Springer-Verlag; 2010. p. 74\u2013199."},{"key":"106_CR19","first-page":"147","volume":"19","author":"W Thoma","year":"2005","unstructured":"Thoma W, Kr\u00e4mer H-J, Mayser P. Pityriasis versicolor alba. JEADV. 2005;19:147\u201352.","journal-title":"JEADV"},{"key":"106_CR20","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1439-0507.1998.tb00336.x","volume":"41","author":"P Mayser","year":"1998","unstructured":"Mayser P, Wille G, Imkampe A, Thoma W, Arnold N, Monsees T. Synthesis of fluorochromes and pigments in Malassezia furfur by use of tryptophan as the single nitrogen source. Mycoses. 1998;41:265\u201371.","journal-title":"Mycoses"},{"issue":"Suppl 1","key":"106_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/mmy\/myx134","volume":"56","author":"B Theelen","year":"2018","unstructured":"Theelen B, Cafarchia C, Gaitanis G, Bassukas ID, Boekhout T, Dawson TL. Malassezia ecology, pathophysiology, and treatment. Med Mycol. 2018;56(Suppl 1):10\u201325.","journal-title":"Med Mycol"},{"key":"106_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.clindermatol.2009.12.015","volume":"28","author":"LJ Mendez-Tovar","year":"2010","unstructured":"Mendez-Tovar LJ. Pathogenesis of dermatophytosis and tinea versicolor. Clin Dermatol. 2010;28:185\u20139.","journal-title":"Clin Dermatol"},{"key":"106_CR23","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1001\/jama.2018.12429","volume":"320","author":"A Hudson","year":"2018","unstructured":"Hudson A, Sturgeon A, Peiris A. Tinea versicolor. JAMA. 2018;320:1396.","journal-title":"JAMA"},{"key":"106_CR24","first-page":"108","volume":"5","author":"JC Szepietowski","year":"2000","unstructured":"Szepietowski JC, Baran E, Wild E. Tinea versicolor: a prospective study. Korean J Med Mycol. 2000;5:108\u201312.","journal-title":"Korean J Med Mycol"},{"key":"106_CR25","doi-asserted-by":"publisher","first-page":"444","DOI":"10.5021\/ad.2012.24.4.444","volume":"24","author":"HJ Park","year":"2012","unstructured":"Park HJ, Lee YW, Choe YB, Ahn KJ. Skin characteristics in patients with Pityriasis versicolor using non-invasive method, MPA5. Ann Dermatol. 2012;24:444\u201352.","journal-title":"Ann Dermatol"},{"key":"106_CR26","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.1128\/JCM.43.8.4147-4151.2005","volume":"43","author":"G Gaitanis","year":"2005","unstructured":"Gaitanis G, Chasapi V, Velegraki A. Novel application of the masson-Fontana stain for demonstrating Malassezia species melanin-like pigment production in vitro and in clinical specimens. J Clin Microbiol. 2005;43:4147\u201351.","journal-title":"J Clin Microbiol"},{"key":"106_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4103\/2349-5847.135440","volume":"1","author":"D Gupta","year":"2014","unstructured":"Gupta D, Thappa DM. The enigma of color in tinea versicolor. Pigment Int. 2014;1:32\u20135.","journal-title":"Pigment Int"},{"issue":"Suppl 1","key":"106_CR28","first-page":"16","volume":"16","author":"V Crespo Erchiga","year":"1999","unstructured":"Crespo Erchiga V, Ojeda Martos AA, Vera Casa\u00f1o A, Crespo Erchiga A, S\u00e1nchez FF. Isolation and identification of Malassezia spp. in pytiriasis versicolor, seborrheic dermatitis and healthy skin. Rev Iberoam Micol. 1999;16(Suppl 1):16\u201321.","journal-title":"Rev Iberoam Micol"},{"key":"106_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/ijd.12345","volume":"53","author":"JR Kallini","year":"2014","unstructured":"Kallini JR, Riaz F, Khachemoune A. Tinea versicolor in dark-skinned individuals. Int J Dermatol. 2014;53:137\u201341.","journal-title":"Int J Dermatol"},{"key":"106_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.7241\/ourd.20171.11","volume":"8","author":"R Acharya","year":"2017","unstructured":"Acharya R, Gyawalee M. Uncommon presentation of Pityriasis versicolor; hyper and hypopigmentation in a same patient with variable treatment response. Our Dermatol Online. 2017;8:43\u20135.","journal-title":"Our Dermatol Online"},{"key":"106_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2147\/CCID.S195166","volume":"12","author":"M Mathur","year":"2019","unstructured":"Mathur M, Acharya P, Karki A, Kc N, Shah J. Dermoscopic pattern of pityriasis versicolor. Clin Cosmet Investig Dermatol. 2019;12:303\u20139.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"106_CR32","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/BF00372617","volume":"282","author":"KU Schallreuter","year":"1990","unstructured":"Schallreuter KU, Wood JW. A possible mechanism of action for azelaic acid in the human epidermis. Arch Dermatol Res. 1990;282:168\u201371.","journal-title":"Arch Dermatol Res"},{"key":"106_CR33","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/cbic.200400247","volume":"6","author":"H-J Kr\u00e4mer","year":"2005","unstructured":"Kr\u00e4mer H-J, Podobinska M, Bartsch A, et al. Malassezin, a novel agonist of the aryl hydrocarbon receptor from the yeast Malassezia furfur, induces apoptosis in primary human melanocytes. ChemBioChem. 2005;6:860\u20135.","journal-title":"ChemBioChem"},{"key":"106_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/978-3-642-03616-3_4","volume-title":"Malassezia and the skin: science and clinical practice","author":"P Mayser","year":"2010","unstructured":"Mayser P, Gaitanis G. Physiology and biochemistry. In: Boekhout T, Gu\u00e9ho E, Mayser P, Velegraki A, editors. Malassezia and the skin: science and clinical practice. Berlin Heidelberg: Springer-Verlag; 2010. p. 121\u201337."},{"key":"106_CR35","doi-asserted-by":"publisher","first-page":"e01853","DOI":"10.1128\/mBio.01853-16","volume":"7","author":"G Ianiri","year":"2016","unstructured":"Ianiri G, Averette AF, Kingsbury JM, Heitman J, Idnurm A. Gene function analysis in the ubiquitous human commensal and pathogen Malassezia genus. mBio. 2016;7:e01853\u201316.","journal-title":"mBio"},{"key":"106_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/jof1010013","volume":"1","author":"AK Gupta","year":"2015","unstructured":"Gupta AK, Foley KA. Antifungal treatment for pityriasis versicolor. J Fungi (Basel). 2015;1:13\u201329.","journal-title":"J Fungi (Basel)"},{"key":"106_CR37","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1093\/mmy\/myu010","volume":"52","author":"FD Rojas","year":"2014","unstructured":"Rojas FD, Sosa Mde L, Fern\u00e1ndez MS, Cattana ME, C\u00f3rdoba SB, Giusiano GE. Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method. Med Mycol. 2014;52:641\u20136.","journal-title":"Med Mycol"},{"key":"106_CR38","volume-title":"CLSI document M27-A3","author":"CLSI","year":"2008","unstructured":"CLSI. Reference method for broth dilution antifungal susceptibility testing of yeast; approved standard. In: CLSI document M27-A3. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.","edition":"3"},{"key":"106_CR39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.vetmic.2011.04.027","volume":"152","author":"FPK Jesus","year":"2011","unstructured":"Jesus FPK, Lautert C, Zanette RA, et al. In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles. Vet Microbiol. 2011;152:161\u20134.","journal-title":"Vet Microbiol"},{"key":"106_CR40","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1099\/jmm.0.078709-0","volume":"63","author":"R Iatta","year":"2014","unstructured":"Iatta R, Figueredo LA, Montagna MT, Otranto D, Cafarchia C. In vitro antifungal susceptibility of Malassezia furfur from bloodstream infections. J Med Microbiol. 2014;63:1467\u201373.","journal-title":"J Med Microbiol"},{"key":"106_CR41","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/myc.12577","volume":"60","author":"R Iatta","year":"2017","unstructured":"Iatta R, Puttilli MR, Immediato D, Otranto D, Cafarchia C. The role of drug efflux pumps in Malassezia pachydermatis and Malassezia furfur defence against azoles. Mycoses. 2017;60:178\u201382.","journal-title":"Mycoses"},{"key":"106_CR42","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1128\/CMR.12.4.501","volume":"12","author":"MA Ghannoum","year":"1999","unstructured":"Ghannoum MA, Rice LB. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev. 1999;12:501\u201317.","journal-title":"Clin Microbiol Rev"},{"key":"106_CR43","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1046\/j.1365-4362.2001.01156.x","volume":"40","author":"AK Gupta","year":"2001","unstructured":"Gupta AK. Ciclopirox: an overview. Int J Dermatol. 2001;40:305\u201310.","journal-title":"Int J Dermatol"},{"key":"106_CR44","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2165\/00128071-200001020-00001","volume":"1","author":"J Faergemann","year":"2000","unstructured":"Faergemann J. Management of seborrheic dermatitis and pityriasis versicolor. Am J Clin Dermatol. 2000;1:75\u201380.","journal-title":"Am J Clin Dermatol"},{"key":"106_CR45","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1046\/j.1468-3083.2002.00378.x","volume":"16","author":"AK Gupta","year":"2002","unstructured":"Gupta AK, Bluhm R, Summerbell R. Pityriasis versicolor. J Eur Acad Dermatol Venereol. 2002;16:19\u201333.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"106_CR46","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1365-2230.1989.tb00908.x","volume":"14","author":"V Villars","year":"1989","unstructured":"Villars V, Jones TC. Clinical efficacy and tolerability of terbinafine (Lamisil) \u2013 a new topical and systemic fungicidal drug for treatment of dermatomycoses. Clin Exp Dermatol. 1989;14:124\u20137.","journal-title":"Clin Exp Dermatol"},{"key":"106_CR47","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/j.1567-1364.2008.00359.x","volume":"8","author":"LC Paulino","year":"2008","unstructured":"Paulino LC, Tseng C-H, Blaser MJ. Analysis of Malassezia microbiota in healthy superficial human skin and in psoriatic lesions by multiplex real-time PCR. FEMS Yeast Res. 2008;8:460\u201371.","journal-title":"FEMS Yeast Res"},{"key":"106_CR48","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00284-017-1237-7","volume":"74","author":"A Ilahi","year":"2017","unstructured":"Ilahi A, Hadrich I, Neji S, Trabelsi H, Makni F, Ayadi A. Real-time PCR identification of six Malassezia species. Curr Microbiol. 2017;74:671\u20137.","journal-title":"Curr Microbiol"},{"key":"106_CR49","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1046\/j.1439-0507.2002.00757.x","volume":"45","author":"T Murai","year":"2002","unstructured":"Murai T, Nakamura Y, Kano R, Watanabe S, Hasegawa A. Differentiation of Malassezia furfur and Malassezia sympodialis by glycine utilization. Mycoses. 2002;45:180\u20133.","journal-title":"Mycoses"}],"container-title":["BMC Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12895-020-00106-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12895-020-00106-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12895-020-00106-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T23:49:31Z","timestamp":1632872971000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcdermatol.biomedcentral.com\/articles\/10.1186\/s12895-020-00106-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["106"],"URL":"https:\/\/doi.org\/10.1186\/s12895-020-00106-x","relation":{},"ISSN":["1471-5945"],"issn-type":[{"value":"1471-5945","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]},"assertion":[{"value":"17 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval not applicable to this case report. Written informed consents for publication of clinical details and clinical images were obtained from the patient and his wife (non-patient).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient and his wife for publication of this case report and any accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors have no competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}